Heather Preston

Insider Reports History

Entity
Individual
Location
C/O Aligos Therapeutics, Inc., One Corporate Drive, 2 Nd Floor, South San Francisco, CA
Signature
/s/ Lesley Ann Calhoun, as attorney-in fact for Heather Preston
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Heather Preston:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Karuna Therapeutics, Inc. Director Common Stock 6.56K $2.08M $316.81 Jun 24, 2021 Direct
Karuna Therapeutics, Inc. Director Option (right to buy) 8.5K $785K $92.30 Jun 16, 2021 Direct
Aligos Therapeutics, Inc. Director Stock Option (Right to Buy) 120K Aug 7, 2024 Direct
Fusion Pharmaceuticals Inc. Director Stock Option (Right to Buy) 17K Jun 14, 2023 Direct
Akouos, Inc. Director Common Stock 0 $12.50 Nov 30, 2022 Direct
Akouos, Inc. Director Stock Option (right to buy) 0 Dec 1, 2022 Direct

Insider Reports Filed by Heather Preston

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALGS Aligos Therapeutics, Inc. Aug 7, 2024 1 $0 4 Aug 9, 2024 Director
ALGS Aligos Therapeutics, Inc. Aug 7, 2024 0 $0 3 Aug 9, 2024 Director
FUSN Fusion Pharmaceuticals Inc. Jun 14, 2023 1 $0 4 Jun 14, 2023 Director
AKUS Akouos, Inc. Nov 30, 2022 2 $0 4 Dec 2, 2022 Director
AKUS Akouos, Inc. Jun 23, 2022 1 $0 4 Jun 27, 2022 Director
FUSN Fusion Pharmaceuticals Inc. Jun 14, 2022 1 $0 4 Jun 22, 2022 Director
KRTX Karuna Therapeutics, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director
AKUS Akouos, Inc. Jun 24, 2021 1 $0 4 Jun 25, 2021 Director
KRTX Karuna Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 23, 2021 Director
FUSN Fusion Pharmaceuticals Inc. Jun 4, 2021 1 $0 4 Jun 7, 2021 Director